Dylan Fisher was 27 and training for a marathon in 2019 when a routine physical led to a type 2 diabetes diagnosis. “The diagnosis just felt off,” he said.
If you live in the San Francisco Bay area, you might see Lindsay Tyson cruising around town on her green Kawasaki Ninja motorcycle. Or you could catch her doing flying trapeze at the circus school, where she teaches in her spare time.
When you take part in TrialNet type 1 diabetes (T1D) risk screening, a few drops of blood can make a big difference. In addition to learning your risk for developing T1D—often years before symptoms appear—you’re joining the TrialNet #T1Dfamily, the world’s largest clinical trial network ever assembled to change the course of T1D.
Tracy Olsten shares why her daughter Mikayla participated in the landmark Teplizumab prevention trial
With landmark results recently announced, the Teplizumab Prevention Study is making headlines across the country. Here, Tracy Olsten shares why her daughter Mikayla decided to join the study.
Elliot, a 17-year-old from a small village outside Bristol, recently completed treatment in the Abatacept Prevention Study. He is the first person in the United Kingdom (UK) to do so.
The Maguire family is united in fighting the war on T1D. To participate in TrialNet research, they travel from Sault Ste. Marie, Ontario, to the Hospital for Sick Children at the University of Toronto every 6 months. That's a 7.5-hour drive, often through plenty of snow!
As a nurse, Jessica Hamer was no stranger to type 1 diabetes (T1D) when her 4-year-old son Garrus started showing signs of the disease. She said, “I just kept thinking, it can’t be type 1.” But it was, and Garrus was diagnosed with the disease in the spring of 2017.